Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine-Based Chemotherapy with Haploidentical Lymphocyte Infusion for Elderly AML
NCT02662647Phase 2Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Apr 2015
- Primary completion
- Jun 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of haploidentical lymphocyte infusion in acute myeloid leukemia (AML), sponsored by Chinese PLA General Hospital. Started Apr 2015; status: completed.
02
Drugs
haploidentical lymphocyte infusion
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02662647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662647.